Patents by Inventor Jeremy Ewan Turnbull

Jeremy Ewan Turnbull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS
    Publication number: 20180228834
    Abstract: The present invention relates to the use of heparin derivatives for the prevention and/or treatment of cancer and/or cancer metastasis. The heparin derivatives are substantially 2-O and/or 6-O desulphated heparins which function as inhibitors of galectin-3 activity.
    Type: Application
    Filed: April 12, 2018
    Publication date: August 16, 2018
    Inventors: Jeremy Ewan TURNBULL, Edwin Alexander YATES, Jonathan Michael RHODES, Lu-Gang YU
  • Agents for the prevention and/or treatment of central nervous system damage
    Patent number: 9889150
    Abstract: The present invention relates to the use of agents (including heparin derivatives) for the prevention and/or treatment of CNS damage.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: February 13, 2018
    Assignees: The University Of Liverpool, The University Court of the University of Glasgow
    Inventors: Jeremy Ewan Turnbull, Scott Ernest Guimond, Sophie Marie Thompson, Susan Carol Barnett, Jennifer Rosemary Higginson
  • Prevention And/Or Treatment Of Cancer And/Or Cancer Metastasis
    Publication number: 20160113959
    Abstract: The present invention relates to the use of heparin derivatives for the prevention and/or treatment of cancer and/or cancer metastasis. The heparin derivatives are substantially 2-O and/or 6-O desulphated heparins which function as inhibitors of galectin-3 activity.
    Type: Application
    Filed: December 28, 2015
    Publication date: April 28, 2016
    Inventors: Jeremy Ewan TURNBULL, Edwin Alexander YATES, Jonathan Michael RHODES, Lu-Gang YU
  • AGENTS FOR THE PREVENTION AND/OR TREATMENT OF CENTRAL NERVOUS SYSTEM DAMAGE
    Publication number: 20150272984
    Abstract: The present invention relates to the use of agents (including heparin derivatives) for the prevention and/or treatment of CNS damage.
    Type: Application
    Filed: November 1, 2013
    Publication date: October 1, 2015
    Applicants: THE UNIVERSITY OF LIVERPOOL, THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW
    Inventors: Jeremy Ewan Turnbull, Scott Ernest Guimond, Sophie Marie Thompson, Susan Carol Barnett, Jennifer Rosemary Higginson
  • PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS
    Publication number: 20140235573
    Abstract: The present invention relates to the use of heparin derivatives for the prevention and/or treatment of cancer and/or cancer metastasis. The heparin derivatives are substantially 2-O and/or 6-O desulphated heparins which function as inhibitors of galectin-3 activity.
    Type: Application
    Filed: October 1, 2012
    Publication date: August 21, 2014
    Inventors: Jeremy Ewan Turnbull, Edwin Alexander Yates, Jonathan Michael Rhodes, Lu-Gang Yu
  • Sequence analysis of saccharide material
    Patent number: 6589757
    Abstract: A method of analyzing and sequencing saccharide material composed of saccharide chains. The saccharide chains are end referenced, e.g., by labeling or tagging at their reducing ends, and the saccharide material is subjected to a controlled partial depolymerisation using a selection scission reagent, for example, low pH nitrous acid, which cleaves internal glycosidic linkages in accordance with known linkage specificity so as to produce a mixed set of saccharide chain fragments having different lengths ranging throughout the full spectrum of possible lengths for the particular glycosidic linkage specificity of the selective scission reagent employed. Samples of the mixed set of saccharide chain fragments are then treated with selected exoenzymes including exoglycosidases that cleave only particular glycosidic linkages at the non-reducing end of saccharide chains. These exoenzymes are applied to the samples either singly or in combination in accordance with a predetermined strategy.
    Type: Grant
    Filed: October 20, 1997
    Date of Patent: July 8, 2003
    Assignee: Cancer Research Technology Limited
    Inventors: John Thomas Gallagher, Jeremy Ewan Turnbull, John Joseph Hopwood